10Jan/13

Phase III data in The Lancet show significant benefit of Novartis drug … – International Business Times (press release)

Phase III data in The Lancet show significant benefit of Novartis drug
International Business Times (press release)
10, 2013 /PRNewswire/ — Data published today in The Lancet showed that patients on Afinitor® (everolimus) tablets with non-cancerous kidney tumors known as renal angiomyolipomas associated with tuberous sclerosis complex (TSC) experienced a

and more »

10Jan/13

Study finds increase in unused transplant livers

NEW YORK (Reuters Health) – The number of donor livers thrown away in the U.S. has increased since 2004 due – in part – to a population growing older and heavier, according to a new study that also points to changes in medical practice that may make some donor livers less viable. “The rationale for looking at this question in the first place is that the number of liver transplants done in the U …